Neurologist Implicated In Insider Trading Case

摘要

Federal authorities filed charges last week in what they said is the most lucrative insider trading case in history. According to the Securities and Exchange Commission (SEC), Sidney Gilman, a neurology professor at the University of Michigan, Ann Arbor, fed secret information about clinical trials of an Alzheimer's drug to Mathew Martoma, a former portfolio manager at a division of the hedge fund SAC Capital Advisors, allowing Martoma to make more than $276 million in illicit profits and avoid losses with well-timed stock purchases and sales.